Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Ansell · SciRah

Researcher profile · Semantic Scholar

S. Ansell

Share profile

S. Ansell — researcher profile on SciRah

h-index: 73
Works: 496
Citations: 23K

Most-cited papers

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
S. Ansell, J. Radford, J. Connors, M. Długosz-Danecka +17 more
2022New England Journal of Medicine274 citations Open access
Semantic Scholar
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results
R. Advani, A. Moskowitz, N. Bartlett, J. Vose +13 more
2021Blood213 citations
Semantic Scholar
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
R. Bannerji, J. Arnason, R. Advani, Jennifer R. Brown +15 more
2022The Lancet Haematology187 citations Open access
Semantic Scholar
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
S. Horwitz, S. Ansell, Wei-Yun Z. Ai, J. Barnes +32 more
2022The Journal of the National Comprehensive Cancer Network132 citations Open access
Semantic Scholar
Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management
S. Ansell
2022American journal of hematology/oncology113 citations Open access
Semantic Scholar
Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study
S. Ansell, P. Bröckelmann, G. von Keudell, Hun Lee +17 more
2023Blood Advances94 citations Open access
Semantic Scholar
Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression
N. Bennani, HyoJin Kim, L. Pederson, P. Atherton +6 more
2022Journal for ImmunoTherapy of Cancer68 citations Open access
Semantic Scholar
Does Bridging Radiation Therapy Affect the Pattern of Failure After CAR T-cell Therapy in Non-Hodgkin Lymphoma?
O. Saifi, W. Breen, S. Lester, W. Rule +21 more
2021Radiotherapy and Oncology60 citations Open access
Semantic Scholar
Expression of KLRG1 and CD127 defines distinct CD8+ subsets that differentially impact patient outcome in follicular lymphoma
Hongyan Wu, Xin-Yi Tang, H. Kim, S. Jalali +5 more
2021Journal for ImmunoTherapy of Cancer41 citations Open access
Semantic Scholar
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma
Sanjal H. Desai, M. Spinner, K. David, V. Bachanova +26 more
2023American journal of hematology/oncology35 citations Open access
Semantic Scholar
Insights into the tumor microenvironment of B cell lymphoma
W.L. Ng, S. Ansell, P. Mondello
2022Journal of experimental & clinical cancer research : CR35 citations Open access
Semantic Scholar
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
Vaishali Bhardwaj, S. Ansell
2023Frontiers in Cell and Developmental Biology33 citations Open access
Semantic Scholar
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT
W. Breen, M. Hathcock, J. Young, R. Kowalchuk +11 more
2022Journal of Hematology & Oncology30 citations Open access
Semantic Scholar
Don't put the CART before the horse: The role of radiation therapy in peri-CAR T-cell therapy for aggressive B-cell non-Hodgkin lymphoma.
O. Saifi, W. Breen, S. Lester, W. Rule +18 more
2022International Journal of Radiation Oncology, Biology, Physics28 citations
Semantic Scholar
Incidence and Risk Factors for Acute Kidney Injury following Chimeric Antigen Receptor T-Cell (CAR-T) therapy
Naba Farooqui, J. P. Sy-Go, Jing Miao, Ramila A. Mehta +13 more
2022Mayo Clinic proceedings28 citations Open access
Semantic Scholar
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity
W. Breen, Jason R. Young, M. Hathcock, R. Kowalchuk +12 more
2023Blood Cancer Journal25 citations Open access
Semantic Scholar
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia
S. Zanwar, Jennifer G. Le-Rademacher, E. Durot, S. D'Sa +21 more
2024Journal of Clinical Oncology23 citations Open access
Semantic Scholar
Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19
Xiao-Sheng Wu, M. Manske, Gordon J. Ruan, Taylor L. Witter +15 more
2023iScience20 citations Open access
Semantic Scholar
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS)
Jacqui-Lyn Saw, M. Sidiqi, M. Ruff, S. Hocker +22 more
2022Blood Cancer Journal19 citations Open access
Semantic Scholar
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
J. Wiedmeier-Nutor, M. Iqbal, A. Rosenthal, Evandro D. Bezerra +31 more
2023Clinical Lymphoma, Myeloma & Leukemia18 citations Open access
Semantic Scholar
Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell Lymphoma
P. Mondello, S. Ansell, G. Nowakowski
2022Frontiers in Genetics18 citations Open access
Semantic Scholar
T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma
Zhi-Zhang Yang, HyoJin Kim, Hongyan Wu, Xinyi Tang +14 more
2023Blood Cancer Journal17 citations Open access
Semantic Scholar
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course
D. O'Donoghue, H. Truong, Heidi D. Finnes, Jennifer S. McDonald +18 more
2022JCO Oncology Practice17 citations
Semantic Scholar
Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma
A. Feldman, Naoki Oishi, R. Ketterling, S. Ansell +2 more
2022American Journal of Surgical Pathology16 citations Open access
Semantic Scholar
Final Results of a Phase II Study of CHOEP Plus Lenalidomide as Initial Therapy for Patients with Stage II-IV Peripheral T-cell Lymphoma
Robert N. Stuver, S. Horwitz, R. Advani, J. Vose +10 more
2023British Journal of Haematology15 citations Open access
Semantic Scholar
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
O. Saifi, W. Breen, S. Lester, W. Rule +18 more
2023Haematologica15 citations Open access
Semantic Scholar
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
R. King, Alia Gupta, P. Kurtin, W. Ding +16 more
2022Blood Cancer Journal15 citations Open access
Semantic Scholar
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience
M. Melody, Sangeetha Gandhi, H. Saunders, Z. Abdelrahman +20 more
2022Leukemia and Lymphoma15 citations
Semantic Scholar
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
A. Castellino, A. Tun, Yucai Wang, T. Habermann +8 more
2021Blood Cancer Journal15 citations Open access
Semantic Scholar
PD-1 Blockade in Classic Hodgkin Lymphoma.
S. Ansell
2021JCO Oncology Practice15 citations
Semantic Scholar
The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel
K. Wudhikarn, R. Bansal, A. Khurana, M. Hathcock +7 more
2021Blood Cancer Journal14 citations Open access
Semantic Scholar
Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma
T. Anagnostou, Zhi-Zhang Yang, S. Jalali, HyoJin Kim +9 more
2023Leukemia12 citations Open access
Semantic Scholar
HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
S. Ansell, P. Bröckelmann, G. von Keudell, Hun Lee +15 more
202111 citations
Semantic Scholar
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
Allison M. Bock, J. Gile, M. Larson, K. Poonsombudlert +15 more
2023Blood Cancer Journal10 citations Open access
Semantic Scholar
First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1.
S. Ansell, J. Connors, J. Radford, W. Kim +16 more
2022Journal of Clinical Oncology10 citations
Semantic Scholar
Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma
Clifford M. Csizmar, S. Ansell
2021International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
E. Hawkes, T. Phillips, L. Budde, A. Santoro +14 more
2021Targeted oncology10 citations Open access
Semantic Scholar
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
Sanjal H. Desai, M. Spinner, A. Evens, A. Sýkorová +30 more
2023Blood Advances9 citations Open access
Semantic Scholar
Outcomes of older adults with non-Hodgkin lymphoma undergoing autologous stem cell transplantation: a Mayo Clinic Cohort Analysis.
K. Wudhikarn, Bradley M. Johnson, D. Inwards, L. Porrata +6 more
2022Transplantation and Cellular Therapy9 citations Open access
Semantic Scholar
A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome
Karan L. Chohan, J. Young, S. Lester, Muhamad Alhaj Moustafa +7 more
2022Blood Advances9 citations Open access
Semantic Scholar
Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma
A. Khurana, M. Hathcock, T. Habermann, Abdullah S. Al Saleh +11 more
2021American journal of hematology/oncology9 citations
Semantic Scholar
Outpatient practice utilization for CAR-T and T cell engager in patients with lymphoma and multiple myeloma.
R. Bansal, J. Paludo, Andre De Menezes Silva Corraes, Spychalla Megan +16 more
2023Journal of Clinical Oncology8 citations Open access
Semantic Scholar
T-Cell Lymphomas, Version 2.2022
S. Horwitz, S. Ansell, Wei-Yun Z. Ai, J. Barnes +32 more
20228 citations
Semantic Scholar
Current salvage therapies in Hodgkin lymphoma
Karan L. Chohan, S. Ansell
2022Leukemia and Lymphoma8 citations
Semantic Scholar
Long‐term outcome of immunologic autograft engineering
L. Porrata, D. Inwards, S. Ansell, I. Micallef +4 more
2022eJHaem7 citations Open access
Semantic Scholar
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
J. Gile, Camden L. Lopez, Gordon J. Ruan, M. Hathcock +12 more
2021Blood Cancer Journal7 citations Open access
Semantic Scholar
Checkpoint BLOCKade in Lymphoma.
S. Ansell
2021Journal of Clinical Oncology7 citations
Semantic Scholar
PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphoma.
P. Mondello, S. Ansell
2021Cancer Cell7 citations Open access
Semantic Scholar
Peak absolute lymphocyte count after CAR‐T infusion predicts clinical response in aggressive lymphoma
R. Bansal, M. Novo, Abdullah S. Al Saleh, Anatilde M. Gonzalez Guerrico +14 more
2022American journal of hematology/oncology6 citations Open access
Semantic Scholar
Oral Abstract: HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
C. Carlo-Stella, S. Ansell, P. Zinzani, J. Radford +22 more
2022Clinical Lymphoma, Myeloma & Leukemia6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Paludo×21
Invite
J. Paludo — researcher profile on SciRah
Yucai Wang×14
Invite
Yucai Wang — researcher profile on SciRah
P. Johnston×13
Invite
P. Johnston — researcher profile on SciRah
M. Hathcock×12
Invite
M. Hathcock — researcher profile on SciRah

×12

Invite

J. Villasboas — researcher profile on SciRah

Invite

A. Khurana — researcher profile on SciRah

Invite

R. Bansal — researcher profile on SciRah

Invite

R. Advani — researcher profile on SciRah

Invite

N. Bennani — researcher profile on SciRah

A. Rosenthal×7

Invite

A. Rosenthal — researcher profile on SciRah

Invite

Yi Lin — researcher profile on SciRah

Invite

N. Bennani — researcher profile on SciRah